Tech Company Financing Transactions
Paradigm Diagnostics Funding Round
On 2/17/2017, Paradigm Diagnostics raised $7 million in Series B investment from Mesa Verde Venture Partners and New Science Ventures.
Transaction Overview
Company Name
Announced On
2/17/2017
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series B
Investors
Mesa Verde Venture Partners (Lead Investor)
New Science Ventures (Grace Colón)
Proceeds Purpose
This financing will help us to more broadly provide our solution to oncologists and patients.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
445 N. 5th St. 300
Phoenix, AZ 85004
USA
Phoenix, AZ 85004
USA
Phone
Website
Email Address
Not Recorded
Overview
Paradigm Diagnostics, Inc is a molecular information corporation established to bring comprehensive and clinically actionable cancer genomic profiling to physicians and patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Mallery
Chief Scientific Officer
Scott Morris
VP - Bus. Development
Bret Gustafson
VP - Operations
Troy Shelton
VP - R & D
Ariane Kemkes
VP - Sales
Michael Ostromecki
VP - Sales
Thomas Strilko
Browse more venture capital transactions:
Prev: 2/17/2017: ReplyYes venture capital transaction
Next: 2/17/2017: TetraVue venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs